1970
DOI: 10.1677/joe.0.0470137
|View full text |Cite
|
Sign up to set email alerts
|

EFFECT OF INTRAVENOUS INFUSION OF d-MANNOHEPTULOSE ON BLOOD GLUCOSE AND INSULIN LEVELS IN MAN

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1972
1972
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Among pharmacologic inhibitors of insulin secretion, propranolol, mannoheptulose, and 2-deoxy-glucose are not able to inhibit as many diverse stimuli for insulin release as somatostatin (25,(27)(28)(29). Diazoxide and diphenylhydantoin are widely effective inhibitors of insulin secretion (25,30), but their in vivo effectiveness does not match that of somatostatin (31,32).…”
Section: Discussionmentioning
confidence: 99%
“…Among pharmacologic inhibitors of insulin secretion, propranolol, mannoheptulose, and 2-deoxy-glucose are not able to inhibit as many diverse stimuli for insulin release as somatostatin (25,(27)(28)(29). Diazoxide and diphenylhydantoin are widely effective inhibitors of insulin secretion (25,30), but their in vivo effectiveness does not match that of somatostatin (31,32).…”
Section: Discussionmentioning
confidence: 99%
“…Interest in the potential therapeutic activity of MH was stimulated by early studies in humans demonstrating its potential for treating hypoglycemia. When MH was delivered intravenously, a major increase in blood glucose was observed accompanied by a marked decrease in blood insulin. , The mechanism for the enhanced blood glucose levels was purported to be MH-induced inhibition of pancreatic β cells to produce insulin. Further clinical application of synthetic MH was impractical given the high cost of its production.…”
Section: Introductionmentioning
confidence: 99%
“…The potential therapeutic benefits of MH were identified in early human studies focused on its potential for improving hypoglycemia [ 8 , 9 ]. Major increases in blood glucose levels could be produced via iv delivery of MH with concomitant decreases in serum insulin levels.…”
Section: Introductionmentioning
confidence: 99%